UnknownPhase 3

Dexmedetomidine Adjuvant in Retinal Surgery

Saudi Arabia90 participantsStarted 2014-01

Plain-language summary

During LA in retinal surgery there is some problem as regard the lack of anaesthesia duration and unexpected globe movement .so many adjuvant was added to LA to overcome this disadvantages of LA such as clonidine and fentanyl . The investigators hypothesis is adding dexmedetomidine to pribulbal blocking LA will prolong anaesthesia duration and improve globe akinesia and decrease intraoperative supplementation of LA.There are Many studies had described the effects of dexmedetomidine on peripheral nerve blocks, spinal but up to date no knowledge is available on the impact of dexmedetomidine adjuvant to local anaesthetic in ophthalmic surgery

Who can participate

Age range40 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients * Going for elective vitreoretinal surgery. Exclusion Criteria: * History of coagulation abnormalities. * Allergy to local anesthetics. * Cardiac, hepatic or renal failure, * Chronic clonidine or analgesic therapy. * One-eyed patients

What they're measuring

onset, duration of the motor and sensory block

Timeframe: 10 minutes from injection

Trial details

NCT IDNCT02282787

SponsorKing Saud University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-01

View on ClinicalTrials.gov More Peribulbar Anesthesia trials